A phase I clinical trial multiple ascending dose study of COR388 in older healthy volunteers and AD patients.
Phase of Trial: Phase I
Latest Information Update: 09 Jan 2018
At a glance
- Drugs COR-388 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- 09 Jan 2018 New trial record